J&J(JNJ) Seeking Alpha·2025-05-20 19:10Core Insights - Johnson & Johnson is navigating a challenging healthcare environment characterized by unprecedented tariffs and policy changes, particularly with respect to Part D redesign [3][4]. - The company reported a 400 million impact from tariffs in its first quarter results, primarily affecting its MedTech segment, but remains optimistic about growth despite these challenges [4][5]. Group 1: Tariffs and Financial Outlook - The current tariff situation is unprecedented, leading to significant policy discussions that impact the healthcare sector [3]. - Johnson & Johnson anticipates a 2 billion discount impact from Part D redesign, yet aims to grow through these challenges rather than contract its growth expectations [4]. - The company has absorbed an additional $400 million impact in its 2025 outlook due to tariffs, indicating resilience in its financial strategy [5].